Loading...
Sign in to edit your profile (add interests, mentoring, photo, etc.)

    Marc Riedl

    TitleClinical Professor
    SchoolUniversity of California, San Diego
    DepartmentMedicine
    Address9500 Gilman Drive #0876
    CA La Jolla 92093
    Phone858-657-5350
    vCardDownload vCard

      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Riedl M. Angioedema: Challenges and Insights. Immunol Allergy Clin North Am. 2017 Aug; 37(3):xv-xvi. PMID: 28687115.
        View in: PubMed
      2. Chen M, Riedl M. Emerging Therapies in Hereditary Angioedema. Immunol Allergy Clin North Am. 2017 Aug; 37(3):585-595. PMID: 28687111.
        View in: PubMed
      3. Riedl M, Grivcheva-Panovska V, Moldovan D, Baker J, Yang WH, Giannetti BM, Reshef A, Andrejevic S, Lockey RF, Hakl R, Kivity S, Harper JR, Relan A, Cicardi M. Recombinant human C1 esterase inhibitor for prophylaxis of hereditary angio-oedema: a phase 2, multicentre, randomised, double-blind, placebo-controlled crossover trial. Lancet. 2017 Jul 25. PMID: 28754491.
        View in: PubMed
      4. Geng B, Eastman JJ, Mori K, Braskett M, Riedl M. Utility of minor determinants for skin testing in inpatient penicillin allergy evaluation. Ann Allergy Asthma Immunol. 2017 Sep; 119(3):258-261. PMID: 28743423.
        View in: PubMed
      5. Riedl M, Banerji A, Busse PJ, Johnston DT, Davis-Lorton MA, Patel S, Parr H, Chiao J, Watson DJ, Burrell E, Machnig T. Patient satisfaction and experience with intravenously administered C1-inhibitor concentrates in the United States. Ann Allergy Asthma Immunol. 2017 Jul; 119(1):59-64. PMID: 28668241.
        View in: PubMed
      6. Longhurst H, Cicardi M, Craig T, Bork K, Grattan C, Baker J, Li HH, Reshef A, Bonner J, Bernstein JA, Anderson J, Lumry WR, Farkas H, Katelaris CH, Sussman GL, Jacobs J, Riedl M, Manning ME, Hebert J, Keith PK, Kivity S, Neri S, Levy DS, Baeza ML, Nathan R, Schwartz LB, Caballero T, Yang W, Crisan I, Hernandez MD, Hussain I, Tarzi M, Ritchie B, Králícková P, Guilarte M, Rehman SM, Banerji A, Gower RG, Bensen-Kennedy D, Edelman J, Feuersenger H, Lawo JP, Machnig T, Pawaskar D, Pragst I, Zuraw BL. Prevention of Hereditary Angioedema Attacks with a Subcutaneous C1 Inhibitor. N Engl J Med. 2017 03 23; 376(12):1131-1140. PMID: 28328347.
        View in: PubMed
      7. Bernstein JA, Relan A, Harper JR, Riedl M. Sustained response of recombinant human C1 esterase inhibitor for acute treatment of hereditary angioedema attacks. Ann Allergy Asthma Immunol. 2017 Apr; 118(4):452-455. PMID: 28284978.
        View in: PubMed
      8. Busse P, Baker J, Martinez-Saguer I, Bernstein JA, Craig T, Magerl M, Riedl M, Shapiro R, Frank M, Lumry W, Rosch J, Edelman J, Williams-Herman D, Feuersenger H, Rojavin M. Safety of C1-inhibitor concentrate use for hereditary angioedema in pediatric patients. J Allergy Clin Immunol Pract. 2017 Jul - Aug; 5(4):1142-1145. PMID: 28286153.
        View in: PubMed
      9. Craig T, Shapiro R, Vegh A, Baker JW, Bernstein JA, Busse P, Magerl M, Martinez-Saguer I, Riedl M, Lumry W, Williams-Herman D, Edelman J, Feuersenger H, Machnig T, Rojavin M. Efficacy and safety of an intravenous C1-inhibitor concentrate for long-term prophylaxis in hereditary angioedema. Allergy Rhinol (Providence). 2017 Mar 01; 8(1):13-19. PMID: 28381322.
        View in: PubMed
      10. Banerji A, Busse P, Shennak M, Lumry W, Davis-Lorton M, Wedner HJ, Jacobs J, Baker J, Bernstein JA, Lockey R, Li HH, Craig T, Cicardi M, Riedl M, Al-Ghazawi A, Soo C, Iarrobino R, Sexton DJ, TenHoor C, Kenniston JA, Faucette R, Still JG, Kushner H, Mensah R, Stevens C, Biedenkapp JC, Chyung Y, Adelman B. Inhibiting Plasma Kallikrein for Hereditary Angioedema Prophylaxis. N Engl J Med. 2017 02 23; 376(8):717-728. PMID: 28225674.
        View in: PubMed
      11. Baker JW, Reshef A, Moldovan D, Harper JR, Relan A, Riedl M. Recombinant Human C1-Esterase Inhibitor to Treat Acute Hereditary Angioedema Attacks in Adolescents. J Allergy Clin Immunol Pract. 2017 Jul - Aug; 5(4):1091-1097. PMID: 28202404.
        View in: PubMed
      12. Magerl M, Frank M, Lumry W, Bernstein J, Busse P, Craig T, Martinez-Saguer I, Riedl M, Shapiro R, Edelman J, Williams-Herman D, Wood DN, Feuersenger H, Rojavin M. Short-term prophylactic use of C1-inhibitor concentrate in hereditary angioedema: Findings from an international patient registry. Ann Allergy Asthma Immunol. 2016 Nov 16. PMID: 27865714.
        View in: PubMed
      13. Otani IM, Lumry WR, Hurwitz S, Li HH, Craig TJ, Holtzman NS, Iandoli MI, Tucker J, Riedl M, Zuraw BL, Banerji A. Subcutaneous Icatibant for the Treatment of Hereditary Angioedema Attacks: Comparison of Home Self-Administration with Administration at a Medical Facility. J Allergy Clin Immunol Pract. 2016 Nov 3. PMID: 27818136.
        View in: PubMed
      14. Riedl M, Lumry WR, Li HH, Banerji A, Bernstein JA, Ba M, Bjrkander J, Magerl M, Maurer M, Rockich K, Chen H, Schranz J. Subcutaneous administration of human C1 inhibitor with recombinant human hyaluronidase in patients with hereditary angioedema. Allergy Asthma Proc. 2016 Nov; 37(6):489-500. PMID: 27931305.
        View in: PubMed
      15. Frank MM, Zuraw B, Banerji A, Bernstein JA, Craig T, Busse P, Christiansen S, Davis-Lorton M, Li HH, Lumry WR, Riedl M. Management of Children With Hereditary Angioedema Due to C1 Inhibitor Deficiency. Pediatrics. 2016 Nov; 138(5). PMID: 27940765.
        View in: PubMed
      16. Otani IM, Christiansen SC, Busse P, Camargo CA, Zuraw BL, Riedl M, Banerji A. Emergency Department Management of Hereditary Angioedema Attacks: Patient Perspectives. J Allergy Clin Immunol Pract. 2017 Jan - Feb; 5(1):128-134.e4. PMID: 27665386.
        View in: PubMed
      17. Riedl M, Bygum A, Lumry W, Magerl M, Bernstein JA, Busse P, Craig T, Frank MM, Edelman J, Williams-Herman D, Feuersenger H, Rojavin M. Safety and Usage of C1-Inhibitor in Hereditary Angioedema: Berinert Registry Data. J Allergy Clin Immunol Pract. 2016 Sep-Oct; 4(5):963-71. PMID: 27286778.
        View in: PubMed
      18. Doshi A, Tse K, Riedl M, Zuraw B, Christiansen S. Cases of acquired C1 inhibitor deficiency treated with rituximab. J Allergy Clin Immunol Pract. 2016 Sep-Oct; 4(5):987-8. PMID: 27130715.
        View in: PubMed
      19. Banerji A, Riedl M. Managing the female patient with hereditary angioedema. Womens Health (Lond Engl). 2016 Jun; 12(3):351-61. PMID: 26978558.
        View in: PubMed
      20. Lumry WR, Farkas H, Moldovan D, Toubi E, Baptista J, Craig T, Riedl M. Icatibant for Multiple Hereditary Angioedema Attacks across the Controlled and Open-Label Extension Phases of FAST-3. Int Arch Allergy Immunol. 2015; 168(1):44-55. PMID: 26556097.
        View in: PubMed
      21. Riedl M. Recombinant Human C1 Esterase Inhibitor in the Management of Hereditary Angioedema. Clin Drug Investig. 2015 Jul; 35(7):407-17. PMID: 26091744.
        View in: PubMed
      22. Geng B, Thakor A, Clayton E, Finkas L, Riedl M. Factors associated with negative histamine control for penicillin allergy skin testing in the inpatient setting. Ann Allergy Asthma Immunol. 2015 Jul; 115(1):33-8. PMID: 25959032.
        View in: PubMed
      23. Banerji A, Busse P, Christiansen SC, Li H, Lumry W, Davis-Lorton M, Bernstein JA, Frank M, Castaldo A, Long JF, Zuraw BL, Riedl M. Current state of hereditary angioedema management: A patient survey. Allergy Asthma Proc. 2015 May; 36(3):213-7. PMID: 25976438.
        View in: PubMed
      24. Riedl M, Lumry WR, Busse P, Levy H, Steele T, Dayno J, Li HH. Prevalence of hereditary angioedema in untested first-degree blood relatives of known subjects with hereditary angioedema. Allergy Asthma Proc. 2015 May; 36(3):206-12. PMID: 25803135.
        View in: PubMed
      25. Christiansen SC, Bygum A, Banerji A, Busse P, Li H, Lumry W, Davis-Lorton M, Bernstein JA, Frank MM, Castaldo A, Long JF, Riedl M, Zuraw BL. Before and after, the impact of available on-demand treatment for HAE. Allergy Asthma Proc. 2015 Mar; 36(2):145-50. PMID: 25715243.
        View in: PubMed
      26. Riedl M. Critical appraisal of androgen use in hereditary angioedema: a systematic review. Ann Allergy Asthma Immunol. 2015 Apr; 114(4):281-288.e7. PMID: 25707325.
        View in: PubMed
      27. Li HH, Moldovan D, Bernstein JA, Reshef A, Porebski G, Stobiecki M, Baker J, Levy R, Relan A, Riedl M. Recombinant human-c1 inhibitor is effective and safe for repeat hereditary angioedema attacks. J Allergy Clin Immunol Pract. 2015 May-Jun; 3(3):417-23. PMID: 25680925.
        View in: PubMed
      28. Bernstein JA, Riedl M, Zacek L, Shapiro RS. Facilitating home-based treatment of hereditary angioedema. Allergy Asthma Proc. 2015 Mar; 36(2):92-9. PMID: 25551795.
        View in: PubMed
      29. Riedl M, Banerji A, Gower R. Current Medical Management of Hereditary Angioedema: Follow-up Survey of US Physicians. J Allergy Clin Immunol Pract. 2015 Mar-Apr; 3(2):220-7. PMID: 25609328.
        View in: PubMed
      30. Craig TJ, Li HH, Riedl M, Bernstein JA, Lumry WR, MacGinnitie AJ, Stolz LE, Biedenkapp J, Chyung Y. Characterization of anaphylaxis after ecallantide treatment of hereditary angioedema attacks. J Allergy Clin Immunol Pract. 2015 Mar-Apr; 3(2):206-212.e4. PMID: 25609335.
        View in: PubMed
      31. Li HH, Busse P, Lumry WR, Frazer-Abel A, Levy H, Steele T, Dayno J, Riedl M. Comparison of chromogenic and ELISA functional c1 inhibitor tests in diagnosing hereditary angioedema. J Allergy Clin Immunol Pract. 2015 Mar-Apr; 3(2):200-5. PMID: 25609336.
        View in: PubMed
      32. Riedl M. The therapeutic landscape for hereditary angioedema: more change on the horizon? Ann Allergy Asthma Immunol. 2014 Oct; 113(4):337-8. PMID: 25256026.
        View in: PubMed
      33. Moellman JJ, Bernstein JA, Lindsell C, Banerji A, Busse PJ, Camargo CA, Collins SP, Craig TJ, Lumry WR, Nowak R, Pines JM, Raja AS, Riedl M, Ward MJ, Zuraw BL, Diercks D, Hiestand B, Campbell RL, Schneider S, Sinert R. A consensus parameter for the evaluation and management of angioedema in the emergency department. Acad Emerg Med. 2014 Apr; 21(4):469-84. PMID: 24730413.
        View in: PubMed
      34. Riedl M. Reply. J Allergy Clin Immunol Pract. 2014 Mar-Apr; 2(2):239-40. PMID: 24607059.
        View in: PubMed
      35. Riedl M, Bernstein JA, Li H, Reshef A, Lumry W, Moldovan D, Farkas H, Levy R, Baker J, Hardiman Y, Totoritis MC, Relan A, Cicardi M. Recombinant human C1-esterase inhibitor relieves symptoms of hereditary angioedema attacks: phase 3, randomized, placebo-controlled trial. Ann Allergy Asthma Immunol. 2014 Feb; 112(2):163-169.e1. PMID: 24468257.
        View in: PubMed
      36. Riedl M, Lumry WR, Li HH, Craig TJ, Fitts D, Kalfus I, Uknis ME. Nanofiltered C1 esterase inhibitor for treatment of laryngeal attacks in patients with hereditary angioedema. Am J Rhinol Allergy. 2013 Nov; 27(6):517-21. PMID: 24274230.
        View in: PubMed
      37. Zuraw BL, Banerji A, Bernstein JA, Busse PJ, Christiansen SC, Davis-Lorton M, Frank MM, Li HH, Lumry WR, Riedl M. US Hereditary Angioedema Association Medical Advisory Board 2013 Recommendations for the Management of Hereditary Angioedema Due to C1 Inhibitor Deficiency. J Allergy Clin Immunol Pract. 2013 Sep-Oct; 1(5):458-67. PMID: 24565617.
        View in: PubMed
      38. Riedl M. Creating a comprehensive treatment plan for hereditary angioedema. Immunol Allergy Clin North Am. 2013 Nov; 33(4):471-85. PMID: 24176212.
        View in: PubMed
      39. Riedl M. Hereditary Angioedema with Normal C1-INH (HAE Type III). J Allergy Clin Immunol Pract. 2013 Sep-Oct; 1(5):427-32. PMID: 24565612.
        View in: PubMed
      40. Riedl M, Levy RJ, Suez D, Lockey RF, Baker JW, Relan A, Zuraw BL. Efficacy and safety of recombinant C1 inhibitor for the treatment of hereditary angioedema attacks: a North American open-label study. Ann Allergy Asthma Immunol. 2013 Apr; 110(4):295-9. PMID: 23535096.
        View in: PubMed
      41. Lumry WR, Bernstein JA, Li HH, MacGinnitie AJ, Riedl M, Soteres DF, Craig TJ, Campion M, Iarrobino R, Stolz LE, Pullman WE. Efficacy and safety of ecallantide in treatment of recurrent attacks of hereditary angioedema: open-label continuation study. Allergy Asthma Proc. 2013 Mar-Apr; 34(2):155-61. PMID: 23484891.
        View in: PubMed
      42. Baker JW, Craig TJ, Riedl M, Banerji A, Fitts D, Kalfus IN, Uknis ME. Nanofiltered C1 esterase inhibitor (human) for hereditary angioedema attacks in pregnant women. Allergy Asthma Proc. 2013 Mar-Apr; 34(2):162-9. PMID: 23484892.
        View in: PubMed
      43. Li HH, Campion M, Craig TJ, Soteres DF, Riedl M, Lumry WR, MacGinnitie AJ, Shea EP, Bernstein JA. Analysis of hereditary angioedema attacks requiring a second dose of ecallantide. Ann Allergy Asthma Immunol. 2013 Mar; 110(3):168-72. PMID: 23548526.
        View in: PubMed
      44. Geng B, Riedl M. HAE update: special considerations in the female patient with hereditary angioedema. Allergy Asthma Proc. 2013 Jan-Feb; 34(1):13-8. PMID: 23406930.
        View in: PubMed
      45. Zuraw BL, Bork K, Binkley KE, Banerji A, Christiansen SC, Castaldo A, Kaplan A, Riedl M, Kirkpatrick C, Magerl M, Drouet C, Cicardi M. Hereditary angioedema with normal C1 inhibitor function: consensus of an international expert panel. Allergy Asthma Proc. 2012 Nov-Dec; 33 Suppl 1:S145-56. PMID: 23394603.
        View in: PubMed
      46. Kalfus IN, Gower RG, Riedl M, Bernstein JA, Lumry WR, Frank MM. Hereditary angioedema: implications of treating a rare disease. Ann Allergy Asthma Immunol. 2012 Aug; 109(2):150-1; author reply 151. PMID: 22840260.
        View in: PubMed
      47. Riedl M. Hereditary angioedema therapies in the United States: movement toward an international treatment consensus. Clin Ther. 2012 Mar; 34(3):623-30. PMID: 22386830.
        View in: PubMed
      48. Riedl M, Hurewitz DS, Levy R, Busse PJ, Fitts D, Kalfus I. Nanofiltered C1 esterase inhibitor (human) for the treatment of acute attacks of hereditary angioedema: an open-label trial. Ann Allergy Asthma Immunol. 2012 Jan; 108(1):49-53. PMID: 22192966.
        View in: PubMed
      49. Lumry WR, Li HH, Levy RJ, Potter PC, Farkas H, Moldovan D, Riedl M, Li H, Craig T, Bloom BJ, Reshef A. Randomized placebo-controlled trial of the bradykinin B2 receptor antagonist icatibant for the treatment of acute attacks of hereditary angioedema: the FAST-3 trial. Ann Allergy Asthma Immunol. 2011 Dec; 107(6):529-37. PMID: 22123383.
        View in: PubMed
      50. Parikh N, Riedl M. New therapeutics in C1INH deficiency: a review of recent studies and advances. Curr Allergy Asthma Rep. 2011 Aug; 11(4):300-8. PMID: 21607669.
        View in: PubMed
      51. Riedl M, Gower RG, Chrvala CA. Current medical management of hereditary angioedema: results from a large survey of US physicians. Ann Allergy Asthma Immunol. 2011 Apr; 106(4):316-322.e4. PMID: 21457880.
        View in: PubMed
      52. Riedl M. Update on the acute treatment of hereditary angioedema. Allergy Asthma Proc. 2011 Jan-Feb; 32(1):11-6. PMID: 21262093.
        View in: PubMed
      53. Riedl M, Campion M, Horn PT, Pullman WE. Response time for ecallantide treatment of acute hereditary angioedema attacks. Ann Allergy Asthma Immunol. 2010 Dec; 105(6):430-436.e2. PMID: 21130380.
        View in: PubMed
      54. Zuraw BL, Frank MM, Riedl M. Introduction: New Perspectives in Hereditary Angioedema (HAE): Molecular Mechanisms & Therapeutic Choices: A CME Symposium Presented at the 2009 World Allergy Congress, Buenos Aires, Argentina, December 9, 2009. World Allergy Organ J. 2010 Sep; 3(9 Suppl):S24. PMID: 23282865.
        View in: PubMed
      55. Riedl M. Hereditary angioedema therapy: kallikrein inhibition and bradykinin receptor antagonism. World Allergy Organ J. 2010 Sep; 3(9 Suppl):S34-8. PMID: 23282868.
        View in: PubMed
      56. Cicardi M, Banerji A, Bracho F, Malbrán A, Rosenkranz B, Riedl M, Bork K, Lumry W, Aberer W, Bier H, Bas M, Greve J, Hoffmann TK, Farkas H, Reshef A, Ritchie B, Yang W, Grabbe J, Kivity S, Kreuz W, Levy RJ, Luger T, Obtulowicz K, Schmid-Grendelmeier P, Bull C, Sitkauskiene B, Smith WB, Toubi E, Werner S, Anné S, Björkander J, Bouillet L, Cillari E, Hurewitz D, Jacobson KW, Katelaris CH, Maurer M, Merk H, Bernstein JA, Feighery C, Floccard B, Gleich G, Hébert J, Kaatz M, Keith P, Kirkpatrick CH, Langton D, Martin L, Pichler C, Resnick D, Wombolt D, Fernández Romero DS, Zanichelli A, Arcoleo F, Knolle J, Kravec I, Dong L, Zimmermann J, Rosen K, Fan WT. Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema. N Engl J Med. 2010 Aug 5; 363(6):532-41. PMID: 20818888.
        View in: PubMed
      57. Lin E, Saxon A, Riedl M. Penicillin allergy: value of including amoxicillin as a determinant in penicillin skin testing. Int Arch Allergy Immunol. 2010; 152(4):313-8. PMID: 20185923.
        View in: PubMed
      58. Craig T, Riedl M, Dykewicz MS, Gower RG, Baker J, Edelman FJ, Hurewitz D, Jacobs J, Kalfus I. When is prophylaxis for hereditary angioedema necessary? Ann Allergy Asthma Immunol. 2009 May; 102(5):366-72. PMID: 19492656.
        View in: PubMed
      59. Riedl M, Saxon A, Diaz-Sanchez D. Oral sulforaphane increases Phase II antioxidant enzymes in the human upper airway. Clin Immunol. 2009 Mar; 130(3):244-51. PMID: 19028145.
        View in: PubMed
      60. Riedl M. The effect of air pollution on asthma and allergy. Curr Allergy Asthma Rep. 2008 Apr; 8(2):139-46. PMID: 18417056.
        View in: PubMed
      61. Riedl M, Nel AE. Importance of oxidative stress in the pathogenesis and treatment of asthma. Curr Opin Allergy Clin Immunol. 2008 Feb; 8(1):49-56. PMID: 18188018.
        View in: PubMed
      62. Riedl M, Landaw EM, Saxon A, Diaz-Sanchez D. Initial high-dose nasal allergen exposure prevents allergic sensitization to a neoantigen. J Immunol. 2005 Jun 1; 174(11):7440-5. PMID: 15905593.
        View in: PubMed
      63. Riedl M, Diaz-Sanchez D. Biology of diesel exhaust effects on respiratory function. J Allergy Clin Immunol. 2005 Feb; 115(2):221-8; quiz 229. PMID: 15696072.
        View in: PubMed
      64. Riedl M, Casillas AM. Adverse drug reactions: types and treatment options. Am Fam Physician. 2003 Nov 1; 68(9):1781-90. PMID: 14620598.
        View in: PubMed
      Marc's Networks
      Concepts
      Derived automatically from this person's publications.
      See all (138) concept(s)
      _
      Co-Authors
      People in Profiles who have published with this person.
      See all (3) people
      _
      Similar People
      People who share similar concepts with this person.
      See all (60) people
      _
      Same Department
      Search Department
      Physical Neighbors
      People whose addresses are nearby this person.
      _